Healthcare - Biotechnology - NASDAQ - US
$ 0.7343
-5.77 %
$ 105 M
Market Cap
-1.18
P/E
CASH FLOW STATEMENT
-94 M
OPERATING CASH FLOW
143 M
INVESTING CASH FLOW
149 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Quantum-Si incorporated
| Net Income | -96 M |
| Depreciation & Amortization | 4.16 M |
| Capital Expenditures | -5.27 M |
| Stock-Based Compensation | 8.52 M |
| Change in Working Capital | -6.58 M |
| Others | -6.06 M |
| Free Cash Flow | -99.3 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (96.0) | (132.4) | (95.0) | (36.6) | (35.8) |
| Depreciation & Amortization | 4.2 | 2.6 | 1.0 | 0.9 | 0.8 |
| Deferred Income Tax | 0 | 0 | 0.7 | 0 | 0 |
| Stock Based Compensation | 8.5 | 11.2 | 24.9 | 1.9 | 2.7 |
| Other Operating Activities | (4.2) | 23.8 | 36 K | 2 K | 0.5 |
| Change in Working Capital | (6.6) | 4.3 | 1.5 | 1.2 | 1.1 |
| Cash From Operations | (94.0) | (90.6) | (66.8) | (32.6) | (30.7) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (5.3) | (10.7) | (5.8) | (0.5) | (1.2) |
| Other Items | 148.7 | 147.9 | (445.2) | 0 | 0 |
| Cash From Investing Activities | 143.4 | 137.2 | (450.9) | (0.5) | (1.2) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | (1.8) | 1.7 | 25 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.1 | 1.9 | 5.6 | 35.3 | 18.2 |
| Cash From Financing Activities | 0.1 | 1.9 | 516.6 | 37.0 | 18.2 |
| CHANGE IN CASH | |||||
| Net Change In Cash | 49.5 | 48.5 | (1.1) | 4.0 | (13.7) |
| FREE CASH FLOW | |||||
| Free Cash Flow | (99.3) | (101.3) | (72.6) | (33.0) | (31.9) |